首页|米非司酮联合米索前列醇在瘢痕子宫患者早期妊娠药物流产过程中的作用分析

米非司酮联合米索前列醇在瘢痕子宫患者早期妊娠药物流产过程中的作用分析

扫码查看
目的 研究米非司酮联合米索前列醇在瘢痕子宫患者早期妊娠药物流产过程中的作用。方法 选取41例瘢痕子宫早期妊娠(孕5~12周)实施流产患者作为研究组;另选取同期41例非瘢痕子宫早期妊娠实施流产患者作为对照组。两组均实施米非司酮联合米索前列醇药物流产。比较两组应用效果及安全性。结果 两组药物流产完全率比较,差异无统计学意义(P>0。05)。研究组患者不良反应发生率为21。95%,对照组患者不良反应发生率为24。39%,两组患者不良反应发生率比较,差异无统计学意义(P>0。05)。两组月经恢复时间、血人绒毛膜促性腺激素(HCG)恢复至正常时间比较,差异无统计学意义(P>0。05)。结论 瘢痕子宫早期妊娠患者采用米非司酮联合米索前列醇药物流产,药物流产效果、安全性及患者预后恢复等均良好,值得临床推广。
Analysis of the role of mifepristone combined with misoprostol in early pregnancy induced abortion in patients with scarred uterus
Objective To study the effect of mifepristone combined with misoprostol on early pregnancy induced abortion in patients with scarred uterus.Methods 41 patients with early pregnancy(5~12 weeks of pregnancy)undergoing miscarriage due to scarred uterus were selected as the study group;Another 41 patients who underwent early miscarriage in non scarred uterus during the same period were selected as the control group.Both groups underwent medical abortion with a combination of mifepristone and misoprostol.Compare the effectiveness and safety of two sets of applications.Results There was no statistically significant difference in the complete abortion rate between the two groups of medication(P>0.05).The incidence of adverse reactions in the study group was 21.95%,while in the control group it was 24.39%.There was no statistically significant difference in the incidence of adverse reactions between the two groups(P>0.05).There was no statistically significant difference(P>0.05)in the recovery time of menstruation and the time for blood chorionic gonadotropin(HCG)to return to normal between the two groups.Conclusion The use of mifepristone combined with misoprostol for medical abortion in early pregnancy patients with scarred uterus has good efficacy,safety,and patient prognosis recovery,and is worthy of clinical promotion.

MifepristoneMisoprostolScarred uterus

滕萍元

展开 >

连云港市赣榆区妇幼保健院 妇保科,江苏 连云港 222100

米非司酮 米索前列醇 瘢痕子宫

2024

实用妇科内分泌电子杂志

实用妇科内分泌电子杂志

ISSN:
年,卷(期):2024.11(19)